WU, EDWIN SC,CHIU, PETER JS,HSU, MEI-CHI,SHIH, YING-CHU
申请号：
CA2983121
公开号：
CA2983121A1
申请日:
2016.03.24
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention relates to new medical uses of morphinans such as naltrexone, nalmefene and their related derivatives. The present invention relates to Toll-like receptor 4 (TLR4) antagonist compounds, and pharmaceutical formulations thereof, and use thereof for prevention and treatment of autoimmune liver diseases including but not limited to autoimmune hepatitis.
